| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.78B | — | +8.2% |
| R&D Expense | $38.0M | — | +0.0% |
| SG&A Expense | $893.0M | — | +13.6% |
| Operating Income | $2.44B | — | +11.7% |
| Pre-tax Income | $2.43B | — | +11.5% |
| Income Tax | $571.0M | — | +11.7% |
| Net Income | $1.86B | — | +11.0% |
| EPS (Basic) | $4.00 | — | +13.3% |
| EPS (Diluted) | $3.98 | — | +13.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.96B | -21.7% | -25.2% |
| Accounts Receivable | $5.32B | +7.1% | +7.5% |
| Inventory | $2.08B | +1.2% | +4.8% |
| Current Assets | $12.75B | -4.3% | -6.2% |
| Total Assets | $86.31B | -0.6% | +4.4% |
| Current Liabilities | $15.39B | +1.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.24B | — | +3.7% |
| Capital Expenditures | $1.34B | — | +5.7% |
| Investing Cash Flow | -$1.38B | — | -1.1% |
| Financing Cash Flow | -$1.97B | — | -407.2% |
| Free Cash Flow | $898.0M | — | +0.8% |
| +6.3% |
| Long-term Debt | $21.50B | -4.4% | +10.6% |
| Total Liabilities | $46.22B | -1.8% | +6.9% |
| Stockholders' Equity | $38.57B | +0.8% | +1.4% |